Cargando…

The Role of IGF/IGF-IR-Signaling and Extracellular Matrix Effectors in Bone Sarcoma Pathogenesis

SIMPLE SUMMARY: Bone sarcomas are mesenchymal origin tumors. Bone sarcoma patients show a variable response or do not respond to chemotherapy. Notably, improving efficient chemotherapy approaches, dealing with chemoresistance, and preventing metastasis pose unmet challenges in sarcoma therapy. Insul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tzanakakis, George N., Giatagana, Eirini-Maria, Berdiaki, Aikaterini, Spyridaki, Ioanna, Hida, Kyoko, Neagu, Monica, Tsatsakis, Aristidis M., Nikitovic, Dragana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160938/ https://www.ncbi.nlm.nih.gov/pubmed/34069554 http://dx.doi.org/10.3390/cancers13102478

Ejemplares similares

Lumican mediates HTB94 chondrosarcoma cell growth via an IGF-IR/Erk1/2 axis
por: Papoutsidakis, Antonis, et al.
Publicado: (2020)

Proteoglycans in the Pathogenesis of Hormone-Dependent Cancers: Mediators and Effectors
por: Tzanakakis, George, et al.
Publicado: (2020)

Biglycan Interacts with Type I Insulin-like Receptor (IGF-IR) Signaling Pathway to Regulate Osteosarcoma Cell Growth and Response to Chemotherapy
por: Giatagana, Eirini-Maria, et al.
Publicado: (2022)

Lumican in Carcinogenesis—Revisited
por: Giatagana, Eirini-Maria, et al.
Publicado: (2021)

Glycosaminoglycans: Carriers and Targets for Tailored Anti-Cancer Therapy
por: Berdiaki, Aikaterini, et al.
Publicado: (2021)

The Landscape of Small Leucine-Rich Proteoglycan Impact on Cancer Pathogenesis with a Focus on Biglycan and Lumican
por: Berdiaki, Aikaterini, et al.
Publicado: (2023)

Proteoglycans—Biomarkers and Targets in Cancer Therapy
por: Nikitovic, Dragana, et al.
Publicado: (2018)

Matrix Effectors in the Pathogenesis of Keratinocyte-Derived Carcinomas
por: Kavasi, Rafaela-Maria, et al.
Publicado: (2022)

Hyaluronan and Reactive Oxygen Species Signaling—Novel Cues from the Matrix?
por: Berdiaki, Aikaterini, et al.
Publicado: (2023)

Cancer Microenvironment and Inflammation: Role of Hyaluronan
por: Nikitovic, Dragana, et al.
Publicado: (2015)

Biglycan Regulates MG63 Osteosarcoma Cell Growth Through a LPR6/β-Catenin/IGFR-IR Signaling Axis
por: Aggelidakis, John, et al.
Publicado: (2018)

Proteoglycans and Immunobiology of Cancer—Therapeutic Implications
por: Tzanakakis, George, et al.
Publicado: (2019)

In Vitro Assessment of Poly-N-Vinylpyrrolidone/Acrylic Acid Nanoparticles Biocompatibility in a Microvascular Endothelium Model
por: Berdiaki, Aikaterini, et al.
Publicado: (2022)

Amphiphilic Poly-N-vinylpyrrolidone Nanoparticles as Carriers for Nonsteroidal, Anti-Inflammatory Drugs: Pharmacokinetic, Anti-Inflammatory, and Ulcerogenic Activity Study
por: Kuskov, Andrey, et al.
Publicado: (2022)

Insulin-Like Growth Factor and Epidermal Growth Factor Signaling in Breast Cancer Cell Growth: Focus on Endocrine Resistant Disease
por: Voudouri, Kallirroi, et al.
Publicado: (2015)

Parathyroid hormone/parathyroid hormone-related peptide regulate osteosarcoma cell functions: Focus on the extracellular matrix (Review)
por: Nikitovic, Dragana, et al.
Publicado: (2016)

Heparin regulates B6FS cell motility through a FAK/actin cytoskeleton axis
por: Voudouri, Kallirroi, et al.
Publicado: (2016)

The Motile Breast Cancer Phenotype Roles of Proteoglycans/Glycosaminoglycans
por: Nikitovic, Dragana, et al.
Publicado: (2014)

Data on the putative role of p53 in breast cancer cell adhesion: Technical information for adhesion assay
por: Voudouri, Kallirroi, et al.
Publicado: (2016)

IGF-IR signaling in epithelial to mesenchymal transition and targeting IGF-IR therapy: overview and new insights
por: Li, Heming, et al.
Publicado: (2017)

Interaction between IGF-IR and ER Induced by E2 and IGF-I
por: Yu, Zhenghong, et al.
Publicado: (2013)

Preface of the Special Issue on the Role of Extracellular Matrix in Development and Cancer Progression
por: Tzanakakis, George, et al.
Publicado: (2022)

Novel cross-talk between IGF-IR and DDR1 regulates IGF-IR trafficking, signaling and biological responses
por: Malaguarnera, Roberta, et al.
Publicado: (2015)

Inflammation and Metabolism in Cancer Cell—Mitochondria Key Player
por: Neagu, Monica, et al.
Publicado: (2019)

IRS-1 acts as an endocytic regulator of IGF-I receptor to facilitate sustained IGF signaling
por: Yoneyama, Yosuke, et al.
Publicado: (2018)

Expression of insulin receptor (IR) A and B isoforms, IGF-IR, and IR/IGF-IR hybrid receptors in vascular smooth muscle cells and their role in cell migration in atherosclerosis
por: Beneit, N., et al.
Publicado: (2016)

Recent developments in the structural characterisation of the IR and IGF1R: implications for the design of IR–IGF1R hybrid receptor modulators
por: Turvey, Samuel J., et al.
Publicado: (2022)

IGF-IR determines the fates of BCR/ABL leukemia
por: Xie, Jingjing, et al.
Publicado: (2015)

IGF-IR Targeted Therapy: Past, Present and Future
por: Janssen, Joseph A. M. J. L., et al.
Publicado: (2014)

Mechanistic understanding of nanoparticles’ interactions with extracellular matrix: the cell and immune system
por: Engin, Ayse Basak, et al.
Publicado: (2017)

Immunolocalization of insulin-like growth factor-I (IGF-I) and its receptors (IGF-IR) in the equine epididymis
por: YOON, Minjung, et al.
Publicado: (2014)

The novel IGF-IR/Akt–dependent anticancer activities of glucosamine
por: Song, Ki-Hoon, et al.
Publicado: (2014)

Cross-Talk between Adiponectin and IGF-IR in Breast Cancer
por: Mauro, Loredana, et al.
Publicado: (2015)

IGF-IR: a new prognostic biomarker for human glioblastoma
por: Maris, C, et al.
Publicado: (2015)

Telomere length as a predictive biomarker in osteoporosis (Review)
por: Kakridonis, Fotios, et al.
Publicado: (2023)

Novel role of cannabinoid receptor 2 in inhibiting EGF/EGFR and IGF-I/IGF-IR pathways in breast cancer
por: Elbaz, Mohamad, et al.
Publicado: (2016)

Stimulatory actions of IGF-I are mediated by IGF-IR cross-talk with GPER and DDR1 in mesothelioma and lung cancer cells
por: Avino, Silvia, et al.
Publicado: (2016)

IGF-IR Internalizes with Caveolin-1 and PTRF/Cavin in Hacat Cells
por: Salani, Barbara, et al.
Publicado: (2010)

IGF-IR Mediated Mammary Tumorigenesis Is Enhanced during Pubertal Development
por: Jones, Robert A., et al.
Publicado: (2014)

Transgenic IGF-IR overexpression induces mammary tumors with basal-like characteristics, whereas IGF-IR-independent mammary tumors express a claudin-low gene signature
por: Franks, S E, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_mck41fcaficdfc538aj9cnch4k